Skip to main content

Table 4 Relationship between baseline characteristics and changes in serum uric acid, and follow-up HbA1c in women

From: Baseline and changes in serum uric acid independently predict glucose control among community-dwelling women

 

Follow up HbA1c

Characteristics N = 393

r (p-value)

F (p-value)

Baseline

 Age

0.056 (0.265)

2.449 (0.118)

 Body mass index

0.157 (0.002)

0.327 (0.568)

 Smoking status

− 0.076 (0.132)

0.166 (0.684)

 Alcohol consumption

− 0.020 (0.699)

1.544 (0.215)

 History of CVD (yes = 1, no = 0)

0.060 (0.237)

1.158 (0.283)

 Systolic blood pressure

0.204 (< 0.001)

0.981 (0.322)

 Diastolic blood pressure

0.139 (0.006)

0.850 (0.357)

 Antihypertensive medication (yes = 1, no = 0)

0.200 (< 0.001)

2.175 (0.141)

 Triglycerides

0.182 (< 0.001)

1.360 (0.244)

 HDL cholesterol

− 0.145 (0.004)

3.825 (0.051)

 LDL cholesterol

0.227 (< 0.001)

13.793 (< 0.001)

 Lipid-lowering medication (yes = 1, no = 0)

0.084 (0.096)

0.325 (0.569)

 eGFR (mL/min/1.73 m2)

0.030 (0.559)

10.715 (0.001)

 HbA1c

0.510 (< 0.001)

118.285 (< 0.001)

 Serum uric acid (SUA)

0.127 (0.012)

9.457 (0.002)

Changes in SUA

0.101 (0.046)

7.757 (0.006)

Baseline SUA*Changes in SUA

–

5.391 (0.021)

R2

–

0.368

  1. r, Pearson’s correlation coefficient; Data for triglycerides and HbA1c were skewed and were log-transformed for analysis
  2. The net effect of each interaction was estimated using a general linear model. Significant values (p < 0.05) are presented in italics